{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/multilingual-documentation-and-country-retention-rules”
},
“@id”: “https://www.clinicalstudies.in/multilingual-documentation-and-country-retention-rules”,
“headline”: “SOP for Multilingual Documentation and Country Retention Rules”,
“name”: “SOP for Multilingual Documentation and Country Retention Rules”,
“description”: “Comprehensive SOP describing sponsor and investigator responsibilities for multilingual documentation preparation and adherence to Swiss country-specific retention requirements for clinical trials.”,
“keywords”: “multilingual documentation SOP Switzerland, Swiss trial document retention SOP, SOP for clinical trial translation Switzerland, SOP for document localization Switzerland, SOP for archiving Swiss trial documents, SOP for multilingual ICFs Switzerland, SOP for sponsor responsibilities Swiss documentation, SOP for BASEC submission multilingual documents, SOP for retention ClinO Switzerland, SOP for inspection readiness Switzerland, SOP for record keeping SOP Switzerland, SOP for document governance Switzerland, SOP for regulatory submissions multilingual Switzerland, SOP for language compliance Swiss clinical trials, SOP for document archival retention Switzerland, SOP for clinical trial document translation QA, SOP for bilingual Swiss trial governance, SOP for translation vendor management Switzerland, SOP for document authenticity Switzerland, SOP for sponsor-site responsibilities Switzerland, SOP for TMF retention Switzerland, SOP for ISF retention Switzerland, SOP for GCP compliance Switzerland, SOP for ethics submission multilingual Switzerland, SOP for patient document translation Switzerland”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

Multilingual Documentation and Country Retention Rules SOP

Purpose

This SOP defines the process for preparing multilingual documentation and complying with Switzerland’s specific retention rules for clinical trial documentation. It ensures that subject-facing documents and regulatory submissions are linguistically and legally compliant under Swissmedic and BASEC requirements.

Scope

This SOP applies to all clinical trials conducted in Switzerland, covering translation, back-translation, certification, and retention of essential trial documents including informed consent forms, patient information sheets, investigator brochures, protocols, and safety reports. It applies to sponsors, investigators, CROs, regulatory affairs, and translation vendors.

Responsibilities

• Sponsor: Ensures multilingual documents are prepared, validated, and archived per ClinO requirements.
• Regulatory Affairs (RA): Submits translated documents to BASEC and Swissmedic as required.
• Principal Investigator (PI): Provides translated subject-facing documents at site and ensures participant comprehension.
• Translation Vendor: Provides certified translations and back-translations of all essential documents.
• Quality Assurance (QA): Audits translated materials and ensures retention timelines are respected.

Accountability

The Sponsor’s Head of Clinical Operations is accountable for multilingual documentation compliance and adherence to Swiss retention rules. The PI is accountable for ensuring subjects receive translated materials in appropriate languages (German, French, Italian).

Procedure

1. Translation and Certification

1. Identify documents requiring translation (ICF, PIS, recruitment materials).
2. Engage certified translators familiar with medical terminology.
3. Perform back-translation to confirm accuracy.
4. File Certificate of Translation Accuracy in TMF (Annexure-1).

2. Submission to BASEC and Swissmedic

1. Submit multilingual documents as part of initial trial dossier or amendments.
2. Record acknowledgment in Submission Log.

3. Subject-Facing Documents

1. Ensure ICFs and PIS are provided in German, French, or Italian depending on trial location.
2. Confirm participant comprehension during the consent process.

4. Retention of Records

1. Maintain TMF and ISF records in compliance with Swiss ClinO retention requirements (at least 10 years).
2. For medical device trials under ClinO-MD, retain records for a minimum of 15 years.
3. Maintain digital backups of archived records.

5. Quality Control and Auditing

1. QA team conducts periodic checks of translated materials.
2. Ensure retention timelines are tracked in Retention Log (Annexure-2).

Abbreviations

• ClinO: Ordinance on Clinical Trials in Human Research
• ClinO-MD: Ordinance on Clinical Trials with Medical Devices
• Swissmedic: Swiss Agency for Therapeutic Products
• BASEC: Business Administration System for Ethics Committees
• ICF: Informed Consent Form
• PIS: Patient Information Sheet
• PI: Principal Investigator
• RA: Regulatory Affairs
• QA: Quality Assurance
• TMF: Trial Master File
• ISF: Investigator Site File

Documents

1. Certificate of Translation Accuracy (Annexure-1)
2. Retention Log (Annexure-2)
3. Submission Log (Annexure-3)

References

• Swissmedic — Clinical Trials
• Swiss Ethics Committees (BASEC)
• ICH E6(R2) Good Clinical Practice

Version: 1.0

Approval

Annexures

Annexure-1: Certificate of Translation Accuracy

Annexure-2: Retention Log

Annexure-3: Submission Log

Revision History

For more SOPs visit: Pharma SOP.